Global Whooping Cough Treatment Market

Whooping Cough Treatment Market Overview

The global Whooping Cough Treatment market was expected to grow at a compound annual growth rate (CAGR) of 6.37% from 2022 to 2028. Pertussis, sometimes known as whooping cough, is a serious respiratory virus that affects children. The market’s growth is linked to the rising global prevalence of whooping cough. The expanding pediatric population is expected to promote market growth, as the illness is more severe in youngsters. Furthermore, rising public health awareness and the adoption of advanced treatment methods are expected to drive market expansion. Moreover, growing pollution levels and high occurrences of various lung and throat illnesses, such as pharyngitis and pneumonia, are important drivers supporting the market’s growth. In addition, the majority of the share can be linked to the region’s high disease burden. The primary factors boosting the market in this region are an increase in cough cases and an increase in the number of children, which is predicted to grow over the forecasted period by 2022-2028.

What is Whooping Cough Treatment?

Pertussis, widely known as whooping cough, is a highly contagious respiratory disease. Bordetella pertussis is the bacteria that causes it. Whooping cough causes mild coughing, sneezing, runny nose, and a low fever. The dry, annoying cough transforms into coughing spells after 1 to 2 weeks. The youngster may make the characteristic whooping sound when breathing in or vomiting at the end of a spell. Whooping cough can be very serious at times, requiring hospitalization. Whooping cough puts babies at the greatest risk of catastrophic problems.

Growth Drivers

Increasing Retail Pharmacy

Retail pharmacy is growing significantly due to its widespread availability and accessibility. MedPlus, for instance, has around 1650 outlets, with 1,350 of them being self-owned and the remainder being franchised. Consumers choose these distribution methods because retailers give discounts on bulk purchases, provide speedy delivery, and have enough product stock. Furthermore, online pharmacy is expected to be the significant market growth over the forecast period. The convenience of having medications delivered to your home is a big benefit of using an online pharmacy. The low prices offered by online pharmacies are also a driving force behind the market’s growth. Moreover, During the forecast period, the rising incidence of whooping cough treatment, which necessitates medication, is expected further to drive the growth of the pharmacy retail market.

Rising population

Whooping cough symptoms range from a low fever, runny nose, and cough to breathing difficulties, whooping, and pneumonia. Because the illness is more severe in children, the market is expected to rise as the pediatric population grows. From 1 billion in 1800 to 7.9 billion in 2020, the world’s population has increased dramatically. According to the United Nations, the population will reach 8.6 billion by mid-2030, 9.8 billion by mid-2050, and 11.2 billion by 2100 globally. Additionally, 61% of the world’s population (4.7 billion) lives in Asia, 17% in Africa (1.3 billion), 10% in Europe (750 million), 8% in Latin America and the Caribbean (650 million), and the remaining 5% in Northern America (370 million) and Oceania (43 million). Therefore, the growing global population is estimated to drive the global market over the forecasted period by 2028.

Pre Covid-19 Impact on Global Whooping Cough Treatment Market

Before the pandemic, the market is expected to increase moderately, owing to factors such as the humid climate, unhealthy lifestyles, and rising disease rates. Collaborations between global organizations and governments from various countries to promote the supply of vital medications and medical supplies are also propelling market expansion.

Covid-19 Impact on Global Whooping Cough Treatment Market

COVID-19 is forecasted to negatively influence the industry’s growth during the projection period due to labor shortages and resource constraints. Furthermore, when government laws regulating lockdowns became more restrictive, the market’s growth slowed. Moreover, it is necessary to develop fresh items that will aid in the fight against the COVID-19 virus. Cough treatments are predicted to rise rapidly throughout the forecast period because of an increase in research activities aimed at developing novel medicines to treat cough produced by the virus.

Post Covid-19 Impact on Global Whooping Cough Treatment Market

Antibiotic resistance infections are projected to rise due to antibiotic abuse or overuse, causing prescription patterns to move to innovative antibiotic therapies to treat bacterial infections. While multinational pharmaceutical companies invest massive amounts of money in creating targeted therapies and treatments, contract development and manufacturing organizations (CDMOs) are looking for ways to increase the production of treatment medications and vaccines. Thus, the market is estimated to have a significant impact post-Covid-19.

By Patient Type Analysis

Based on the patient type, the market is categorized as Pediatrics, Adolescents, Adults, and Others. The Pediatric type is expected to hold a significant share of the global Whooping Cough Treatment market over the forecast period Patients who are 21 years old or younger at the time of diagnosis or treatment are referred to as pediatric patients. Because of the high prevalence and severity of whooping cough among children, the pediatric segment is expected to hold a significant proportion of the worldwide whooping cough treatment market over the forecast period. In most cases, whooping cough leads to pneumonia, a leading cause of death in children.

By Drugs Type Analysis

The market is classified as Antibiotics, Cough syrups, Allergy Suppressants, and Others. The Antibiotics drugs are estimated to have a significant share in the global Whooping Cough Treatment market over the forecasted period by 2028. Antibiotics are antimicrobial substances that are effective against microorganisms. Antibiotic drugs are widely utilized to treat and prevent bacterial infections since they are the most common form of antibacterial agent. Bacteria may be killed or inhibited by these substances. Because of the rising prevalence of infectious diseases, the need for antibiotics is skyrocketing. Collaborations for antibiotic development are expected to develop a large number of antibiotic medications in the forecasted period.

By Region Segment Analysis

The market is bifurcated into North America, Europe, Asia-Pacific, South America, and The Middle East & Africa. North America is likely to have a dominant share of the global Whooping Cough Treatment market over the forecasted period of 2022-2028. Due to an increase in the burden of COVID-19, advanced health care infrastructure, and rising prevalence of chronic obstructive pulmonary disease, flu diseases, whooping cough, and other respiratory infections, North America is expected to dominate the global whooping cough treatment market during the forecast period. These marketplaces are heavily regulated, and the healthcare infrastructure is well-developed. The rising frequency of whooping cough infections and the government’s increasing healthcare spending are key factors driving the North American market.

Competitors Analysis

The Companies include Teva Pharmaceutical Industries Ltd., Pfizer Inc., Abbott Laboratories, Boehringer Ingelheim International GmbH, Siemens Healthcare GmbH, Baxter International, Inc., Daiichi Sankyo Company, Limited, Merck & Co., Inc., Novartis AG, and Other Prominent Players in the Whooping Cough Treatment Market. Key Stakeholders

• Market research and consulting firms
• Industry Associations
• Local Governments
• Regulatory bodies
• Whooping Cough Treatment Market providers
• Suppliers
• Retailers
• Service Providers

Recent Developments

• In May 2021, Teva Pharmaceutical Industries Ltd. announced the launch of its new Erythromycin tablets to treat or overcome a variety of bacterial infections.
• In February 2020, GlaxoSmithKline plc (GSK) and Innoviva, Inc. announced the European Medicines Agency (EMA) approval of Trelegy Ellipta to treat asthma in adults.

Scope of the Report

Report Attribute	Details
Market Size Value in 2021	USD XX Billion
The revenue forecast in 2028	USD XX Billion
Growth Rate	CAGR of 6.37% from 2022 to 2028.
Historical data	2017 – 2020
Base Year	2021
Forecast period	2022 – 2028
Region covered	North America, Europe, Asia-Pacific, South America, and Middle East & Africa
Key companies Profiled	The Companies include Teva Pharmaceutical Industries Ltd., Pfizer Inc., Abbott Laboratories, Boehringer Ingelheim International GmbH, Siemens Healthcare GmbH, Baxter International, Inc., Daiichi Sankyo Company, Limited, Merck & Co., Inc., Novartis AG, and Other Prominent Players in the Whooping Cough Treatment Market.

Market Modelling

By Patient Type

• Pediatric
• Adolescents
• Adults
• Others

By Drug Type

• Antibiotics
• Cough syrups
• Allergy Suppressants
• Others

By End-User

• Hospitals
• Pediatric Clinics
• Online Pharmacy
• Others

By Region

• North America
• Europe
• Asia-Pacific
• South America
• The Middle East & Africa

UK Childcare Software Market Report

Connected Car Market

Parenteral Products Packaging Market

Cold Chain Monitoring Market

Global 3D Food Printing Market

Vibrating Microtome Market

Viral Vectors Manufacturing Market

Feed Pusher Market

Aluminum Extrusion Market